Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
companies
Aeterna Zentaris
Æterna Zentaris Management Discusses Q1 2013 Results - Earnings Call Transcript
Æterna Zentaris Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Aeterna Zentaris
earnings
This Week in Biotech
This Week in Biotech
Motley Fool
Aeterna Zentaris
Navidea Biopharmaceuticals
Sinovac Biotech
Spectrum Pharmaceuticals
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo
Aeterna Zentaris
Multiple Myeloma
perifosine
4 Small Biotechs With Big Clinical Trials Presenting In 2013
4 Small Biotechs With Big Clinical Trials Presenting In 2013
Seeking Alpha
Advaxis
Aeterna Zentaris
APPY1
GCS-100
La Jolla Pharmaceutical
perifosine
Venaxis
Aeterna Zentaris soars on U.S. FDA trial agreement
Aeterna Zentaris soars on U.S. FDA trial agreement
Reuters
Aeterna Zentaris
AEZS-108
endometrial cancer
AEterna Zentaris And Progenics Pharmaceuticals - Rising From The Ashes In 2013?
AEterna Zentaris And Progenics Pharmaceuticals - Rising From The Ashes In 2013?
Seeking Alpha
Aeterna Zentaris
Progenics
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Aeterna Zentaris
Aveo Pharmaceutical
Cell Therapeutics
Chelsea Therapeutics
Exelixis
Progenics Pharmaceuticals
Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Seeking Alpha
Aeterna Zentaris
Celsion
OncoSec Medical
Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Seeking Alpha
Aeterna Zentaris
AEZS-108
AEZS-130
perifosine
A Dismal 2012 May Make For A Good Entry Now For AEterna Zentaris
A Dismal 2012 May Make For A Good Entry Now For AEterna Zentaris
Seeking Alpha
Aeterna Zentaris
1
2
3
4
5
6
7
8
9
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT